Status and phase
Conditions
Treatments
About
This study aims at evaluating the safety and efficacy of Moxidectin 2 mg in patients with low intensities of microfilariae of Loa loa.
Full description
This clinical trial will be randomized, double blind, and will compare Moxidectin to ivermectin. This study will be conducted in Cameroon.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Informed consent written, signed (or with a cross) and dated
Men aged 18 to 65 included (women not included in the study)
Microfilarial density between 1 and 1,000 mf/mL
body weight ≥ 45 kg and less than 85 kg
Good general condition, as determined by the medical questionnaire and clinical examination
Hematological parameters and adequate renal and hepatic functions, such as:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
72 participants in 2 patient groups
Loading...
Central trial contact
Cédric Chesnais, MD; Guy Sadeu Wafeu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal